Nirsevimab for RSV Prevention in Late Preterm and Term Infants | NEJM
Nirsevimab has been shown to help prevent RSV-associated lower respiratory tract infection in healthy preterm infants, but its safety and efficacy in late preterm and term infants are unknown. New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3v8PaxP
Видео Nirsevimab for RSV Prevention in Late Preterm and Term Infants | NEJM канала NEJM Group
To see the full article, follow this link: https://nej.md/3v8PaxP
Видео Nirsevimab for RSV Prevention in Late Preterm and Term Infants | NEJM канала NEJM Group
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Health of a Nation Coverage for All Americans--Part 4
It’s All in the Timing
Preventing Fractures in Osteoporosis
Endovascular Therapy for Large Cerebral Infarction | NEJM
Outcomes with Donor Hearts after Circulatory Death | NEJM
Ebola Cases Time Series
A 47-Year-Old Man with Abdominal and Flank Pain
Hardwiring Patient Engagement to Deliver Better Health
Lobar vs. Sublobar Resection for Peripheral Stage IA NSCLC | NEJM
Intention to Treat Podcast: The Promise and Perils of Psychedelics
Basics of Point-of-Care Lung Ultrasonography (Features of a Normal Lung on Ultrasonography) | NEJM
New Patient-Centered Options for Cancer Treatment
Leaflet Thrombosis in Bioprosthetic Valves?
Pitavastatin to Prevent CV Disease in HIV Infection | NEJM
Facebook Live: Opioid Prescribing and Risk of Long-Term Use
How the Pediatric Boards Are Made with Dr. Andrew Dwyer
Transthoracic Echocardiogram Showing Akinesis on Apical Four-Chamber View
Venous Obstruction of the Thigh: Three-Dimensional View of Venous Thrombosis
NEJM Dialogues -- Maternal and Fetal Medicine
Anticoagulation Timing after Stroke in Atrial Fibrillation | NEJM
Myocardial Bridging | NEJM